Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornelia Braicu

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
International Journal of Molecular Sciences|December 10, 2021
Functional Genomics in Health and DiseaseCornelia Braicu
Journal of Drug Targeting|November 21, 2012
Epigallocatechin gallate induce cell death and apoptosis in triple negative breast cancer cells Hs578TCornelia Braicu, Claudia Gherman
Breast (Edinburgh, Scotland)|September 26, 2013
Another review on triple negative breast cancer. Are we on the right way towards the exit from the labyrinth?Roxana Chiorean, Cornelia Braicu, Ioana Berindan-Neagoe
Wiley Interdisciplinary Reviews. RNA|May 4, 2024
Current advances in circular RNA detection and investigation methods: Are we running in circles?Rareș Drula, Cornelia Braicu, Ioana-Berindan Neagoe
International Journal of Nanomedicine|December 20, 2012
Combining the chemotherapeutic effects of epigallocatechin 3-gallate with siRNA-mediated p53 knock-down results in synergic pro-apoptotic effectsIoana Berindan-Neagoe, Cornelia Braicu, Alexandru Irimie
Current Medicinal Chemistry|July 10, 2013
MicroRNAs and cancer therapy - from bystanders to major playersCornelia Braicu, George A Calin, Ioana Berindan-Neagoe
International Journal of Molecular Sciences|March 29, 2023
Investigating Circular RNAs Using qRT-PCR; Roundup of Optimization and Processing StepsRares Drula, Cornelia Braicu, Sergiu Chira, et al.
Molecular and Cellular Biochemistry|July 25, 2013
p53siRNA therapy reduces cell proliferation, migration and induces apoptosis in triple negative breast cancer cellsCornelia Braicu, Valentina Pileczki, Alexandru Irimie, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 16, 2022
The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?Ancuta Jurj, Calin Ionescu, Ioana Berindan-Neagoe, et al.
Current Pharmaceutical Design|October 25, 2014
NCRNA combined therapy as future treatment option for cancerCornelia Braicu, Cristina Catana, George A Calin, et al.
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
International Journal of Molecular Sciences|December 10, 2021
Functional Genomics in Health and DiseaseCornelia Braicu
Journal of Drug Targeting|November 21, 2012
Epigallocatechin gallate induce cell death and apoptosis in triple negative breast cancer cells Hs578TCornelia Braicu, Claudia Gherman
Breast (Edinburgh, Scotland)|September 26, 2013
Another review on triple negative breast cancer. Are we on the right way towards the exit from the labyrinth?Roxana Chiorean, Cornelia Braicu, Ioana Berindan-Neagoe
Wiley Interdisciplinary Reviews. RNA|May 4, 2024
Current advances in circular RNA detection and investigation methods: Are we running in circles?Rareș Drula, Cornelia Braicu, Ioana-Berindan Neagoe
International Journal of Nanomedicine|December 20, 2012
Combining the chemotherapeutic effects of epigallocatechin 3-gallate with siRNA-mediated p53 knock-down results in synergic pro-apoptotic effectsIoana Berindan-Neagoe, Cornelia Braicu, Alexandru Irimie
Current Medicinal Chemistry|July 10, 2013
MicroRNAs and cancer therapy - from bystanders to major playersCornelia Braicu, George A Calin, Ioana Berindan-Neagoe
International Journal of Molecular Sciences|March 29, 2023
Investigating Circular RNAs Using qRT-PCR; Roundup of Optimization and Processing StepsRares Drula, Cornelia Braicu, Sergiu Chira, et al.
Molecular and Cellular Biochemistry|July 25, 2013
p53siRNA therapy reduces cell proliferation, migration and induces apoptosis in triple negative breast cancer cellsCornelia Braicu, Valentina Pileczki, Alexandru Irimie, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 16, 2022
The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?Ancuta Jurj, Calin Ionescu, Ioana Berindan-Neagoe, et al.
Current Pharmaceutical Design|October 25, 2014
NCRNA combined therapy as future treatment option for cancerCornelia Braicu, Cristina Catana, George A Calin, et al.
Pageof 16